Bronchodilators used to treat asthma could worsen sickle cell disease (SCD) in children and teens, and contribute…
Articles by Ana Pena, PhD
FT-4202, a potential disease-modifying oral treatment for sickle cell disease being developed by Forma Therapeutics, has been…
Jasper Therapeutics has raised an additional $14.1 million to finance the development of its investigational conditioning therapy, JSP191, as…
The U.S. Food and Drug Administration (FDA) has awarded $2 million to support a Phase 2 clinical trial…
A multidisciplinary plan implemented at Yale New Haven Children’s Hospital was able to…
ReachBio Research Labs has created a drug screening platform to discover therapeutic compounds that trigger the production of…
The U.S. Food and Drug Administration (FDA) accepted Novartis’ Biologics License Application (BLA) seeking marketing permission for crizanlizumab (…
Chronic pain in adults with sickle cell disease (SCD), a frequent symptom of the disease, is associated with…
IMR-687, an investigational therapy for sickle cell disease, has been granted Fast Track designation by the U.S.
The California Institute for Regenerative Medicine (CIRM) and the National Heart, Lung and Blood Institute (NHLBI) have entered…